HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lung injury secondary to chemotactic factor-induced leukocyte activation.

Abstract
Intravascular complement activation in rats following thermal injury or vascular infusion of cobra venom factor results in acute lung injury as determined morphologically and measured by increases in lung vascular permeability. The acute lung injury is associated with the early appearance of C5-derived chemotactic activity in the circulation coincident with the development of neutropenia. The lung injury is closely linked to availability of complement and neutrophils and can be prevented by systemic treatment of animals with a combination of superoxide dismutase and catalase, specific inhibitors of toxic oxygen metabolites. These data suggest that intravascular complement activation leads to activation of neutrophils and their intrapulmonary capillary sequestration, and subsequent acute lung injury, which is associated with production and release of oxygen-derived free radicals by C5a-activated blood neutrophils.
AuthorsG O Till, P A Ward
JournalAgents and actions. Supplements (Agents Actions Suppl) Vol. 12 Pg. 383-96 ( 1983) ISSN: 0379-0363 [Print] Switzerland
PMID6340440 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Chemotactic Factors
  • Complement C5
  • Complement C5a
  • Catalase
  • Superoxide Dismutase
Topics
  • Animals
  • Capillary Permeability
  • Catalase (pharmacology)
  • Chemotactic Factors (physiology)
  • Chemotaxis, Leukocyte
  • Complement Activation
  • Complement C5 (physiology)
  • Complement C5a
  • Disease Models, Animal
  • Humans
  • Lung (blood supply)
  • Lung Diseases (etiology, prevention & control)
  • Neutrophils (physiology)
  • Rats
  • Superoxide Dismutase (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: